JPWO2021102107A5 - - Google Patents

Info

Publication number

JPWO2021102107A5

JPWO2021102107A5 JP2022529007A JP2022529007A JPWO2021102107A5 JP WO2021102107 A5 JPWO2021102107 A5 JP WO2021102107A5 JP 2022529007 A JP2022529007 A JP 2022529007A JP 2022529007 A JP2022529007 A JP 2022529007A JP WO2021102107 A5 JPWO2021102107 A5 JP WO2021102107A5

Authority

JP

Japan

Prior art keywords

seq

nucleic acid

sequence

aav vector

gaa

Prior art date

2023-11-28

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 150000007523 nucleic acids Chemical group 0.000 claims description 193
• 239000013607 AAV vector Substances 0.000 claims description 160
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 138
• 229920001184 polypeptide Polymers 0.000 claims description 102
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 102
• 108020004707 nucleic acids Proteins 0.000 claims description 92
• 102000039446 nucleic acids Human genes 0.000 claims description 92
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 83
• 239000012634 fragment Substances 0.000 claims description 81
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 61
• 230000000694 effects Effects 0.000 claims description 54
• 239000013598 vector Substances 0.000 claims description 40
• 230000003248 secreting effect Effects 0.000 claims description 38
• 230000008685 targeting Effects 0.000 claims description 36
• 241001164825 Adeno-associated virus - 8 Species 0.000 claims description 28
• 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 claims description 28
• 102100025947 Insulin-like growth factor II Human genes 0.000 claims description 28
• 230000028327 secretion Effects 0.000 claims description 25
• 230000007781 signaling event Effects 0.000 claims description 25
• 210000004185 liver Anatomy 0.000 claims description 24
• 102100033448 Lysosomal alpha-glucosidase Human genes 0.000 claims description 22
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 22
• 108010028144 alpha-Glucosidases Proteins 0.000 claims description 20
• 230000004048 modification Effects 0.000 claims description 20
• 238000012986 modification Methods 0.000 claims description 20
• 108091029523 CpG island Proteins 0.000 claims description 16
• 102100037362 Fibronectin Human genes 0.000 claims description 16
• 108010002350 Interleukin-2 Proteins 0.000 claims description 16
• 150000001413 amino acids Chemical class 0.000 claims description 14
• 230000015788 innate immune response Effects 0.000 claims description 14
• 108020004705 Codon Proteins 0.000 claims description 13
• 108090000565 Capsid Proteins Proteins 0.000 claims description 12
• 102100023321 Ceruloplasmin Human genes 0.000 claims description 12
• 238000005457 optimization Methods 0.000 claims description 10
• 108020005345 3' Untranslated Regions Proteins 0.000 claims description 8
• 108010067306 Fibronectins Proteins 0.000 claims description 8
• 101150115151 GAA gene Proteins 0.000 claims description 8
• 208000015439 Lysosomal storage disease Diseases 0.000 claims description 8
• 238000001727 in vivo Methods 0.000 claims description 8
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 8
• 238000006467 substitution reaction Methods 0.000 claims description 8
• 101710145225 Cation-independent mannose-6-phosphate receptor Proteins 0.000 claims description 6
• 102100037182 Cation-independent mannose-6-phosphate receptor Human genes 0.000 claims description 6
• 206010053185 Glycogen storage disease type II Diseases 0.000 claims description 6
• 101100236307 Homo sapiens GAA gene Proteins 0.000 claims description 6
• 108010031792 IGF Type 2 Receptor Proteins 0.000 claims description 6
• 102000038460 IGF Type 2 Receptor Human genes 0.000 claims description 6
• 208000020584 Polyploidy Diseases 0.000 claims description 6
• 210000001519 tissue Anatomy 0.000 claims description 6
• 241000701161 unidentified adenovirus Species 0.000 claims description 6
• YNVAHBUBGBLIEY-WGDLNXRISA-N (1e,4e)-1,5-bis(2-hydroxyphenyl)penta-1,4-dien-3-one Chemical group OC1=CC=CC=C1\C=C\C(=O)\C=C\C1=CC=CC=C1O YNVAHBUBGBLIEY-WGDLNXRISA-N 0.000 claims description 4
• 102000008186 Collagen Human genes 0.000 claims description 4
• 108010035532 Collagen Proteins 0.000 claims description 4
• 101001028831 Homo sapiens Cation-independent mannose-6-phosphate receptor Proteins 0.000 claims description 4
• 102100021244 Integral membrane protein GPR180 Human genes 0.000 claims description 4
• 229920001436 collagen Polymers 0.000 claims description 4
• 230000037430 deletion Effects 0.000 claims description 4
• 238000012217 deletion Methods 0.000 claims description 4
• 230000004927 fusion Effects 0.000 claims description 4
• 108020001507 fusion proteins Proteins 0.000 claims description 4
• 102000037865 fusion proteins Human genes 0.000 claims description 4
• 201000004502 glycogen storage disease II Diseases 0.000 claims description 4
• 230000037431 insertion Effects 0.000 claims description 4
• 238000003780 insertion Methods 0.000 claims description 4
• 102000028416 insulin-like growth factor binding Human genes 0.000 claims description 4
• 108091022911 insulin-like growth factor binding Proteins 0.000 claims description 4
• 102220015681 rs145500807 Human genes 0.000 claims description 4
• 125000006850 spacer group Chemical group 0.000 claims description 4
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical group C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
• 241000202702 Adeno-associated virus - 3 Species 0.000 claims description 2
• 229920002527 Glycogen Polymers 0.000 claims description 2
• 208000032007 Glycogen storage disease due to acid maltase deficiency Diseases 0.000 claims description 2
• 239000002299 complementary DNA Substances 0.000 claims description 2
• 230000007812 deficiency Effects 0.000 claims description 2
• 239000003937 drug carrier Substances 0.000 claims description 2
• 229940096919 glycogen Drugs 0.000 claims description 2
• 208000007345 glycogen storage disease Diseases 0.000 claims description 2
• 238000007918 intramuscular administration Methods 0.000 claims description 2
• 238000007913 intrathecal administration Methods 0.000 claims description 2
• 238000001990 intravenous administration Methods 0.000 claims description 2
• 230000002132 lysosomal effect Effects 0.000 claims description 2
• 210000003205 muscle Anatomy 0.000 claims description 2
• 230000035772 mutation Effects 0.000 claims description 2
• 230000002107 myocardial effect Effects 0.000 claims description 2
• 239000002773 nucleotide Substances 0.000 claims description 2
• 125000003729 nucleotide group Chemical group 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims description 2
• 108020003175 receptors Proteins 0.000 claims description 2
• 102000005962 receptors Human genes 0.000 claims description 2
• 210000002966 serum Anatomy 0.000 claims description 2
• 210000002027 skeletal muscle Anatomy 0.000 claims description 2
• 238000007920 subcutaneous administration Methods 0.000 claims description 2
• 239000000203 mixture Substances 0.000 claims 14
• 238000000034 method Methods 0.000 description 15
• 241001082241 Lythrum hyssopifolia Species 0.000 description 1